FOXO TECHNOLOGIES INC. Cost of Revenue
FOXO TECHNOLOGIES INC. (FOXO) reported Cost of Revenue of $132.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-06-06.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2024-06-06
- FOXO TECHNOLOGIES INC. cost of revenue for the quarter ending 2023-12-31 was $62.00K, a 75.30% decline year-over-year.
- FOXO TECHNOLOGIES INC. cost of revenue for the quarter ending 2023-09-30 was $70.00K, a 400.00% increase year-over-year.
- FOXO TECHNOLOGIES INC. cost of revenue for the quarter ending 2023-06-30 was $12.00K, a 69.23% decline year-over-year.
- FOXO TECHNOLOGIES INC. cost of revenue for the quarter ending 2023-03-31 was $13.00K, a 67.50% decline year-over-year.
- FOXO TECHNOLOGIES INC. cost of revenue for fiscal 2023 was $132.00K, a 61.63% decline from fiscal 2022.
- FOXO TECHNOLOGIES INC. cost of revenue for fiscal 2022 was $344.00K, a 186.67% increase from fiscal 2021.
- FOXO TECHNOLOGIES INC. cost of revenue for fiscal 2021 was $120.00K.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month | Cost of Revenue 12 month as first filed |
|---|---|---|---|---|---|
| 2023-12-31 | $62.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-06-06 | $132.00K derived: sum of 2 quarters · filed 2024-06-06 | $144.00K derived: sum of 3 quarters · filed 2024-06-06 | $132.00K 10-K · filed 2024-06-06 | |
| 2023-09-30 | $70.00K 10-Q/A · filed 2024-06-04 | $82.00K derived: sum of 2 quarters · filed 2024-06-04 | $70.00K 10-Q/A · filed 2024-06-04 | $346.00K derived: sum of 4 quarters · filed 2024-06-06 | |
| 2023-06-30 | $12.00K 10-Q · filed 2023-08-10 | $25.00K 10-Q · filed 2023-08-10 | $276.00K derived: sum of 3 quarters · filed 2024-06-06 | $290.00K derived: sum of 4 quarters · filed 2024-06-06 | |
| 2023-03-31 | $13.00K 10-Q · filed 2023-05-11 | $264.00K derived: sum of 2 quarters · filed 2024-06-06 | $278.00K derived: sum of 3 quarters · filed 2024-06-06 | $317.00K derived: sum of 4 quarters · filed 2024-06-06 | |
| 2022-12-31 | $251.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-06 | $265.00K derived: sum of 2 quarters · filed 2024-06-06 | $304.00K derived: sum of 3 quarters · filed 2024-06-06 | $344.00K 10-K · filed 2024-06-06 | $511.00K 10-K · filed 2023-03-31 |
| 2022-09-30 | $14.00K 10-Q · filed 2022-11-21 | $53.00K derived: sum of 2 quarters · filed 2023-08-10 | $93.00K 10-Q · filed 2022-11-21 | $120.00K derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-06-30 | $39.00K 10-Q · filed 2023-08-10 | $79.00K 10-Q · filed 2023-08-10 | $106.00K derived: sum of 3 quarters · filed 2023-08-10 | $137.00K derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | $40.00K 10-Q · filed 2023-05-11 | $67.00K derived: sum of 2 quarters · filed 2023-05-11 | $98.00K derived: sum of 3 quarters · filed 2023-05-11 | ||
| 2021-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $58.00K derived: sum of 2 quarters · filed 2023-03-31 | $120.00K 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $31.00K 10-Q · filed 2022-11-21 | $93.00K 10-Q · filed 2022-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |